Medifast, Inc.

NYQ: MED
Live Quote

📈 ZcoreAI Score

Our AI model analyzes Medifast, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get MED Z-Score →

About Medifast, Inc.

Consumer Cyclical Personal Services
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, essential amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans consisting of 5 & 1 Plan and 5 & 1 ACTIVE Plan, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss without the stress of figuring out what to eat. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.

📊 Fundamental Analysis

Medifast, Inc. demonstrates a profit margin of -4.8%, which is below the sector average, suggesting competitive pressure.

The company recently reported -36.9% revenue growth, which is negative, indicating a recent decline in revenue.

Return on Equity (ROE) is -9.1%, which indicates that capital utilization is currently under pressure.

At a current price of $10.06, MED currently trades near the bottom of its 52-week range (13%), indicating potential value or weakness (Range: $9.22 - $15.46).

🏥 Financial Health

🔴 Profit Margin Weak
Debt/Equity Excellent
🔴 Revenue Growth Weak
🔴 Return on Equity Weak
Beta (Risk) Low Volatility

Key Financials

Market Cap
$110.98M
Trailing P/E
--
Forward P/E
-3.64
Beta (5Y)
0.56
52W High
$15.46
52W Low
$9.22
Avg Volume
252K
Day High
Day Low
Get MED Z-Score on Dashboard 🚀